People. Experience. Thought Leadership.

Many of the nation’s leading healthcare organizations come to PwC for business insights and solutions. From assurance, audit and tax to the full spectrum of advisory services, our people provide outstanding industry knowledge, firsthand experience, and professional skills that range the entire healthcare spectrum. 

For every client, and for every project, we tap into some of the brightest minds and the most relevant industry wisdom, connecting a comprehensive network of resources to provide powerful strategies that help you succeed in a competitive and changing marketplace.

More of PwC’s perspective

Thought leadership

Pharmaceutical and Life Sciences Deals Insights Quarterly

Pharmaceutical and Life Sciences Deals Insights Quarterly
 

Learn more

Pharmaceutical and Life Sciences Deals Insights Quarterly

Pharmaceutical and Life Sciences Deals Insights Quarterly

The second quarter of 2013 showed a decline in deal volume and value in the pharmaceutical and life sciences sector after an uptick in deal activity in the first quarter of 2013 driven by several large transactions. A significant number of announced transactions in the quarter and strong fundamentals suggest heightened activity in the second half of the year.

Pharma 2020: From vision to decision

Pharma 2020: From vision to decision
PwC shares strategic insights for the industry

Read article

Pharma 2020: From vision to decision
PwC shares strategic insights for the industry

Pharma 2020: From vision to decision

The pharmaceutical industry is at a critical juncture. The tools to develop new medicines are materializing, demand is increasing and the barriers to free trade are falling. But pharma faces economic and operational challenges that may impact its ability to capitalize on these new growth opportunities.

Case studies

Intellectual Property Protection

Read case study

Intellectual Property Protection

View webcast

Web page

A non-profit biomedical research organization sought third party consultation and negotiation assistance to license a potential new drug application for an existing compound with multiple potential indications. Their objective was to negotiate and secure a solid up-front payment for the license and establish a significant royalty rate.

Research and development portfolio management

Read case study

Research and development portfolio management

View webcast

Web page

A major pharmaceutical company identified a need to improve its research & development (R&D) portfolio evaluation and prioritization process. Seeking advice, the company turned to the pharmaceutical specialists in PwC's UK valuation & strategy’s group for help.

Multimedia downloads

Prospering in a post-health reform world

View webcast

Prospering in a post-health reform world

View webcast

Webcast

On Friday, April 23rd PwC hosted a webcast, "Health reform: Prospering in a post-reform world". The one hour program hosted by PwC's Health Research Institute explains meaningful details of the reform legislation and the potential ramifications for businesses and the health industries.

Health reform in Massachusetts: a model for the U.S.?

View webcast

Health reform in Massachusetts: a model for the U.S.?

View webcast

Webcast

It’s no coincidence that proposed health reform legislation builds on principles of Massachusetts health reform. Controversial before its enactment, and still a subject of heated debate outside of the state, Massachusetts health reform has gained wide approval from Massachusetts voters. Three years into the project, the Massachusetts Health Connector has reduced uninsured individuals to 2.7% of the population.